Cite
HARVARD Citation
Qi, Y. et al. (2021). Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria. Clinical and translational science. 14 (5), pp. 1894-1905. [Online].